Medicines and clinical research approved in 2023

In 2023, Anvisa stepped up drug approvals, modernized regulations, implemented the QMS, prepared for WHO evaluation with the GBT and increased regulatory publications. Read more here

ELS can help you get your products on these charts! Count on us for registration and all the support you need for medicines.

Please do not hesitate to contact your local ELS consultant or via email

Contact us

We will contact you as soon as possible.